Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Pfizer, which makes Lipitor, donated $29 million to patient groups in 2015. Photo: Scott Olson / Getty Images
The largest pharmaceutical companies donated almost twice as much money to patient advocacy groups in 2015 as they spent on federal lobbying, according to a Kaiser Health News investigation.
The big picture: Critics say drug company money could skew the views and priorities of patient groups, many of which have been silent on rising drug prices.
Go deeper: The Kaiser Health News database of drug companies funding patient groups.